What does Revelation Biosciences, Inc. do?
Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health. The company's lead product candidate is lead product candidate Gemini, a proprietary formulation platform of phosphorylated hexaacyl disaccharide (PHAD), an established…
What is Revelation Biosciences, Inc.'s P/E and P/B ratio?
Revelation Biosciences, Inc. has a P/E ratio of 0.1 and a P/B ratio of 0.21.
What is Revelation Biosciences, Inc.'s debt-to-equity ratio?
Revelation Biosciences, Inc. has a debt-to-equity ratio of 0.07.
How much does Revelation Biosciences, Inc. owe compared with what it owns?
Revelation Biosciences, Inc. owes $0.19 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Revelation Biosciences, Inc.'s Positivity rank?
Revelation Biosciences, Inc. is ranked #55 of 6,774 companies globally and #15 of 4,000 in United States on PositoAI, with a Positivity Score of 25,780.
Does Revelation Biosciences, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Revelation Biosciences, Inc..
Where can I read the latest news about Revelation Biosciences, Inc.?
Recent headlines about Revelation Biosciences, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Revelation Biosciences, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Revelation Biosciences, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.